These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 39025058)
21. “Meta-guidelines” for the management of patients with schizophrenia. Stahl SM; Morrissette DA; Citrome L; Saklad SR; Cummings MA; Meyer JM; O'Day JA; Dardashti LJ; Warburton KD CNS Spectr; 2013 Jun; 18(3):150-162. PubMed ID: 23591126 [TBL] [Abstract][Full Text] [Related]
22. Rising co-payments coincide with unwanted effects on continuity of healthcare for patients with schizophrenia in the Netherlands. van der Lee APM; de Haan L; Beekman ATF PLoS One; 2019; 14(9):e0222046. PubMed ID: 31513629 [TBL] [Abstract][Full Text] [Related]
23. Risperidone: efficacy and safety. Umbricht D; Kane JM Schizophr Bull; 1995; 21(4):593-606. PubMed ID: 8749887 [TBL] [Abstract][Full Text] [Related]
24. The schizophrenia prodrome. White T; Anjum A; Schulz SC Am J Psychiatry; 2006 Mar; 163(3):376-80. PubMed ID: 16513855 [No Abstract] [Full Text] [Related]
25. Treatment of agitation in patients with schizophrenia. Marder SR J Clin Psychiatry; 2008 Jun; 69(6):e17. PubMed ID: 18683992 [TBL] [Abstract][Full Text] [Related]
26. Prospective study of prodromal symptoms in schizophrenic relapse. Heinrichs DW; Carpenter WT Am J Psychiatry; 1985 Mar; 142(3):371-3. PubMed ID: 2857535 [TBL] [Abstract][Full Text] [Related]
27. Analysis of resolution criteria in patients with schizophrenia treated with olanzapine for an acute psychotic episode. Peuskens J; Kaufman L; Van Vleymen B Schizophr Res; 2007 Sep; 95(1-3):169-73. PubMed ID: 17630255 [TBL] [Abstract][Full Text] [Related]
28. Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management. Kane JM J Clin Psychiatry; 2003; 64 Suppl 19():3-5. PubMed ID: 14728083 [No Abstract] [Full Text] [Related]
29. [The effect of neuroleptics on the social behavior disorders of schizophrenic patients]. Mahé V Encephale; 2003 Sep; 29(Pt 2):S28-30. PubMed ID: 14710533 [No Abstract] [Full Text] [Related]
30. Treatment of negative symptoms in schizophrenia: a challenge for clinical research. Schmitt A; Maurus I; Falkai P Eur Arch Psychiatry Clin Neurosci; 2023 Apr; 273(3):525-526. PubMed ID: 36977788 [No Abstract] [Full Text] [Related]
31. "Revealed" Depression and drug treatment for schizophrenia. Knights A; Hirsch SR Arch Gen Psychiatry; 1981 Jul; 38(7):806-11. PubMed ID: 6113822 [TBL] [Abstract][Full Text] [Related]
32. [Incidence of the deficit form in refractory schizophrenia]. Samuelian JC Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037 [TBL] [Abstract][Full Text] [Related]
33. Bcl-2 associated with positive symptoms of schizophrenic patients in an acute phase. Tsai MC; Liou CW; Lin TK; Lin IM; Huang TL Psychiatry Res; 2013 Dec; 210(3):735-8. PubMed ID: 23998360 [TBL] [Abstract][Full Text] [Related]
34. Neuroleptic levels by radioreceptor assay and clinical response during treatment of acute exacerbation of schizophrenia--some preliminary findings. Greenberg JS; Brown WA; Laughren TP; Krantz J Psychopharmacol Bull; 1983; 19(1):74-6. PubMed ID: 6131470 [No Abstract] [Full Text] [Related]
35. Contemporary issues in the field. Gorman JM CNS Spectr; 2005 Dec; 10(12):929. PubMed ID: 16344828 [No Abstract] [Full Text] [Related]
36. Symptomatic presentation and initial treatment for schizophrenia in children and adolescents. Correll CU J Clin Psychiatry; 2010 Nov; 71(11):e29. PubMed ID: 21114942 [TBL] [Abstract][Full Text] [Related]
37. Exacerbation of schizophrenia associated with amantadine. Nestelbaum Z; Siris SG; Rifkin A; Klar H; Reardon GT Am J Psychiatry; 1986 Sep; 143(9):1170-1. PubMed ID: 2875665 [TBL] [Abstract][Full Text] [Related]
38. Rapid Amelioration of Clozapine-Resistant Thought Broadcast in Schizophrenia With High-Dose Right Unilateral Ultrabrief Electroconvulsive Therapy-A Single Case Report. Mayur P; Chakos A J ECT; 2019 Jun; 35(2):e16-e17. PubMed ID: 30531396 [No Abstract] [Full Text] [Related]
39. [Problems with the treatment of schizophrenics in the doctor's office]. Sielk M MMW Fortschr Med; 2003 May; 145 Suppl 2():22-6. PubMed ID: 14579480 [TBL] [Abstract][Full Text] [Related]